MedTrace Logo

Efficacy Assessment of a Novel 3D Cartography-based Targeted Focal Microwave Therapy in Men With Localized Intermediate-risk Prostate Cancer

NCT04582656 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 76

Last updated 2026-04-06

No results posted yet for this study

Summary

Multicenter, prospective, European, single-arm, open-label, 12-month follow-up clinical trial. The purpose of this study is to evaluate the efficacy of a 3D cartography-based targeted microwave ablation for the treatment of the index lesion in patients with intermediate risk prostate cancer.

Conditions

Interventions

DEVICE

Targeted microwave ablation

Targeted ablation of the index tumor with microwaves, by using either a transperineal or a transrectal approach

Sponsors & Collaborators

  • Koelis

    lead INDUSTRY

Principal Investigators

  • Roland VAN VELTHOVEN, MD · Uro Science & Consulting

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
45 Years
Max Age
80 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-11
Primary Completion
2025-07-29
Completion
2025-08-21

Countries

  • Belgium
  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04582656 on ClinicalTrials.gov